Jinha Yu (Ke-Da Yu, Keda Yu)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 23

Top Topics

Epidermal Growth Factor Receptor

Positive Breast Cancer

Sentinel Lymph Node

Top Venues

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Cancer communications (London, England)

Clinical cancer research : an official journal of the American Association for Cancer Research

NPJ breast cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Jinha Yu
Inconsistent Data Between Distant Relapse Events and Breast Cancer-Specific Death Events in India Lidocaine Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Yi-Ming Liu, Jing-Yu Ge, Yu-Fei Chen, Tong Liu, Lie Chen, Cui-Cui Liu, Ding Ma, Yi-Yu Chen, Yu-Wen Cai, Ying-Ying Xu, Zhi-Ming Shao, Jinha Yu
Combined Single-Cell and Spatial Transcriptomics Reveal the Metabolic Evolvement of Breast Cancer during Early Dissemination. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10 (6) (2023)
Yi-Ming Liu, Jing-Yu Ge, Yu-Fei Chen, Tong Liu, Lie Chen, Cui-Cui Liu, Ding Ma, Yi-Yu Chen, Yu-Wen Cai, Ying-Ying Xu, Zhi-Ming Shao, Jinha Yu
Combined Single-Cell and Spatial Transcriptomics Reveal the Metabolic Evolvement of Breast Cancer during Early Dissemination. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10 (6) (2023)
Yi-Ming Liu, Jing-Yu Ge, Yu-Fei Chen, Tong Liu, Lie Chen, Cui-Cui Liu, Ding Ma, Yi-Yu Chen, Yu-Wen Cai, Ying-Ying Xu, Zhi-Ming Shao, Jinha Yu
Combined Single-Cell and Spatial Transcriptomics Reveal the Metabolic Evolvement of Breast Cancer during Early Dissemination. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10 (6) (2023)
Yi-Ming Liu, Jing-Yu Ge, Yu-Fei Chen, Tong Liu, Lie Chen, Cui-Cui Liu, Ding Ma, Yi-Yu Chen, Yu-Wen Cai, Ying-Ying Xu, Zhi-Ming Shao, Jinha Yu
Combined Single-Cell and Spatial Transcriptomics Reveal the Metabolic Evolvement of Breast Cancer during Early Dissemination. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10 (6) (2023)
Yi-Ming Liu, Jing-Yu Ge, Yu-Fei Chen, Tong Liu, Lie Chen, Cui-Cui Liu, Ding Ma, Yi-Yu Chen, Yu-Wen Cai, Ying-Ying Xu, Zhi-Ming Shao, Jinha Yu
Combined Single-Cell and Spatial Transcriptomics Reveal the Metabolic Evolvement of Breast Cancer during Early Dissemination. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10 (6) (2023)
Litong Yao, Qian Hao, Mozhi Wang, Yuhai Chen, Hongyi Cao, Qiang Zhang, Jinha Yu, Yi-Zhou Jiang, Zhiming Shao, Xiang Zhou, Yingying Xu
KLHL29-mediated DDX3X degradation promotes chemosensitivity by abrogating cell cycle checkpoint in triple-negative breast cancer. Oncogene (2023)
Yi-Ming Liu, Jing-Yu Ge, Yu-Fei Chen, Tong Liu, Lie Chen, Cui-Cui Liu, Ding Ma, Yi-Yu Chen, Yu-Wen Cai, Ying-Ying Xu, Zhi-Ming Shao, Jinha Yu
Combined Single-Cell and Spatial Transcriptomics Reveal the Metabolic Evolvement of Breast Cancer during Early Dissemination. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10 (6) (2023)
Yi-Ming Liu, Jing-Yu Ge, Yu-Fei Chen, Tong Liu, Lie Chen, Cui-Cui Liu, Ding Ma, Yi-Yu Chen, Yu-Wen Cai, Ying-Ying Xu, Zhi-Ming Shao, Jinha Yu
Combined Single-Cell and Spatial Transcriptomics Reveal the Metabolic Evolvement of Breast Cancer during Early Dissemination. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Litong Yao, Xiaoyan Liu, Mozhi Wang, Jinha Yu, Shouping Xu, Pengfei Qiu, Zhidong Lv, Xinwen Zhang, Yingying Xu
Predicting Pathological Complete Response in Breast Cancer After Two Cycles of Neoadjuvant Chemotherapy by Tumor Reduction Rate: A Retrospective Case-Control Study. Journal of breast cancer (2023)
Si-Yuan Zhu, Ding Ma, Fu-Gui Ye, Zhi-Ming Shao, Jinha Yu
Homologous recombination deficiency and glycolysis-related pathway in adjuvant chemotherapy for triple-negative breast cancer: A genomic landscape and biomarker assessment of the PATTERN trial. Clinical and translational medicine 11 (9) (2022)
Ting Xu, Ding Ma, Sheng Chen, Rui Tang, Jianling Yang, Chunhui Meng, Yang Feng, Li Liu, Jiangfen Wang, Haojun Luo, Jinha Yu
High GPER expression in triple-negative breast cancer is linked to pro-metastatic pathways and predicts poor patient outcomes. NPJ breast cancer 8 (1) (2022)
Jinha Yu, Jing-Yu Ge, Xi-Yu Liu, Miao Mo, Min He, Zhi-Ming Shao, null null
Cyclophosphamide-Free Adjuvant Chemotherapy for Ovarian Protection in Young Women With Breast Cancer: A Randomized Phase 3 Trial. Journal of the National Cancer Institute 113 (10) (2022)
Yu-Wen Cai, Zhi-Ming Shao, Jinha Yu
De-escalation of five-year adjuvant endocrine therapy in patients with estrogen receptor-low positive (immunohistochemistry staining 1%-10%) breast cancer: Propensity-matched analysis from a prospectively maintained cohort. Cancer 128 (9) (2022)
Li Chen, Yi-Zhou Jiang, Song-Yang Wu, Jiong Wu, Gen-Hong Di, Guang-Yu Liu, Jinha Yu, Lei Fan, Jun-Jie Li, Yi-Feng Hou, Zhen Hu, Can-Ming Chen, Xiao-Yan Huang, A-Yong Cao, Xin Hu, Shen Zhao, Xiao-Yan Ma, Ying Xu, Xiang-Jie Sun, Wen-Jun Chai, Xiaomao Guo, Xizi Chen, Yanhui Xu, Xiao-Yu Zhu, Jian-Jun Zou, Wen-Tao Yang, Zhong-Hua Wang, Zhi-Ming Shao
Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (13) (2022)
Yu-Fei Chen, Ying-Ying Xu, Zhi-Ming Shao, Jinha Yu
Resistance to antibody-drug conjugates in breast cancer: mechanisms and solutions. Cancer communications (London, England) (2022)
Yi-Yu Chen, Jing-Yu Ge, Si-Yuan Zhu, Zhi-Ming Shao, Jinha Yu
Copy number amplification of ENSA promotes the progression of triple-negative breast cancer via cholesterol biosynthesis. Nature communications 13 (1) (2022)
Jinha Yu, Yu-Wen Cai, Song-Yang Wu, Ruo-Hong Shui, Zhi-Ming Shao
Estrogen receptor-low breast cancer: Biology chaos and treatment paradox. Cancer communications (London, England) 41 (10) (2021)
Jingyu Ge, Wenjia Zuo, Yiyu Chen, Zhiming Shao, Jinha Yu
The advance of adjuvant treatment for triple-negative breast cancer. Cancer biology & medicine (2021)
Jinha Yu, Xin Wang, Wan-Kun Chen, Lei Fan, Miao Mo, Han Chen
Tailored duration of adjuvant trastuzumab for human epidermal growth factor receptor 2-positive breast cancer. NPJ precision oncology 4 (2020)
Xiaoqing Jia, Chunjie Li, Lihui Li, Xiaoli Liu, Lisha Zhou, Wenjuan Zhang, Shuaishuai Ni, Yun Lu, Li Chen, Lak Shin Jeong, Jinha Yu, Yingjian Zhang, Jianping Zhang, Simin He, Xin Hu, Hefen Sun, Guangyu Liu, Hu Zhao, Yanmei Zhang, Lijun Jia, Zhi-Ming Shao
Neddylation Inactivation Facilitates FOXO3a Nuclear Export to Suppress Estrogen Receptor Transcription and Improve Fulvestrant Sensitivity. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (12) (2019)
Xi Jin, Xiao-En Xu, Yi-Zhou Jiang, Yi-Rong Liu, Wei Sun, Ya-Jie Guo, Yi-Xing Ren, Wen-Jia Zuo, Xin Hu, Sheng-Lin Huang, Hong-Jie Shen, Fei Lan, Yun-Fei He, Guo-Hong Hu, Gen-Hong Di, Xiang-Huo He, Da-Qiang Li, Suling Liu, Jinha Yu
The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation. Science advances 5 (3) (2019)
Bo Zhang, Men-Yun Chen, Yu-Jun Shen, Xian-Bo Zhuo, Ping Gao, Fu-Sheng Zhou, Bo Liang, Jun Zu, Qin Zhang, Sufyan Suleman, Yi-Hui Xu, Min-Gui Xu, Jin-Kai Xu, Chen-Cheng Liu, Nikolaos Giannareas, Ji-Han Xia, Yuan Zhao, Zhong-Lian Huang, Zhen Yang, Huai-Dong Cheng, Na Li, Yan-Yan Hong, Wei Li, Min-Jun Zhang, Jinha Yu, Guoliang Li, Meng-Hong Sun, Zhen-Dong Chen, Gong-Hong Wei, Zhi-Min Shao
A Large-Scale, Exome-Wide Association Study of Han Chinese Women Identifies Three Novel Loci Predisposing to Breast Cancer. Cancer research 78 (11) (2018)